The Efficacy of CAPCT in Patients With PTCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Infliximab for Immune Checkpoint Inhibitor Associated AKI
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The CARDIOPROTECT Trial
- Status
- RECRUITING
- Phase
- PHASE2
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Post-op Prednisone and Glucose Monitoring in TKA
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)
- Status
- COMPLETED
- Phase
- PHASE1
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2